Kathleen Helm-Bychowski applies her breadth of technical and professional experience in chemistry and biotechnology to assist clients in all areas of patent practice, including patent validity and freedom-to-operate issues, competitor patent landscapes, and patent prosecution. Dr. Helm-Bychowski has experience with technologies including novel chemical compounds, particularly small molecule pharmaceuticals, multi-step syntheses, polymorphs, and pharmaceutical formulations of all types directed to a wide range of therapies. Other technologies include antibody production and purification, biosimilars, personal care product formulations, corn oil and ethanol processing, ink jet inks, artificial sweeteners, processes for copper compounds, and gummy nutraceuticals.
Dr. Helm-Bychowski has 15 years of experience with preparing legal opinions including patent landscape reports, infringement clearance opinions, due diligence, and validity opinions. She has provided technical expertise during litigations, including performing document review, developing arguments and strategies, and working with experts. In addition, Dr. Helm-Bychowski has prepared and prosecuted U.S. and foreign patent applications, and has been involved in an interference proceeding.
Representative matters include: pharmaceutical active compounds, syntheses, and formulations, biosimilars, personal care product formulations, processes for copper compounds, ink jet inks, and an interference pertaining to a method of making copper carbonate salts.
Prior to joining Leydig, Voit and Mayer, Dr. Helm-Bychowski was an assistant professor of biochemistry and chemistry at DePaul University, and a visiting research professor in the Department of Anatomy and Cell Biology at the University of Illinois at Chicago. Her research involved using biochemical techniques such as immunochemistry, restriction enzyme mapping, PCR, and DNA sequencing to study the evolution of organisms, macromolecules, and nuclear/mitochondrial interactions.